Boston-based chemical company 908 Devices has secured $17 million in Series E funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced April 29 and financed by Northpond Ventures.
According to its Crunchbase profile, "908 Devices is bringing the powerful capabilities of Mass Spectrometry out of the confines of centralized facilities and mobile laboratories. We make battery-operated, handheld, chemical detection tools, rugged enough to exceed military standards and trusted enough for immediate action in the field. For biologists and chemists in need of answers, we make personal analyzers, small and simple enough for every workspace."
The seven-year-old company has raised five previous funding rounds, including a $20 million Series D round in 2017.
The round brings total funding raised by Boston companies in manufacturing over the past month to $18 million, an increase of $18 million from the month before. The local manufacturing industry has seen 12 funding rounds over the past year, securing a total of $52 million in venture funding.
In other local funding news, translation service company 3Play Media announced a private equity funding round on May 14, financed by Riverside Partners.
According to Crunchbase, "3Play Media provides a more technologically advanced and cost-effective captioning, audio description, and subtitling solution. We work with more than 2,000 customers across media and entertainment, enterprise and educational institutions. Our methods allow us to reduce the cost and simplify the process, while maintaining premium quality levels."
Founded in 2007, the company has raised two previous rounds, including a $511,601 round in 2011.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
